Vor Bio to Participate in the Oppenheimer's 35th Annual Healthcare Life Sciences Conference
Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, has announced its participation in Oppenheimer's 35th Annual Healthcare Life Sciences Conference. The company will engage in a fireside chat scheduled for Wednesday, February 12th at 12:00pm ET and conduct virtual one-on-one meetings with investors.
The event will be held virtually, and interested parties can access both the live webcast and archived replay of the fireside chat through the investors section of www.vorbio.com.
Vor Bio (Nasdaq: VOR), un'azienda che opera nella fase clinica e si occupa di ingegneria cellulare e genomica, ha annunciato la sua partecipazione alla 35ª Conferenza Annuale sulla Salute e le Scienze della Vita di Oppenheimer. L'azienda prenderà parte a una chat informale in programma per mercoledì 12 febbraio alle 12:00 ET e condurrà incontri virtuali one-on-one con gli investitori.
L'evento si terrà virtualmente e le parti interessate possono accedere sia alla diretta del webcast che alla registrazione archiviata della chat informale attraverso la sezione investitori di www.vorbio.com.
Vor Bio (Nasdaq: VOR), una compañía en etapa clínica de ingeniería celular y genómica, ha anunciado su participación en la 35ª Conferencia Anual de Ciencias de la Salud de Oppenheimer. La compañía participará en una charla informal programada para el miércoles 12 de febrero a las 12:00 p.m. ET y llevará a cabo reuniones virtuales uno a uno con inversores.
El evento se llevará a cabo de forma virtual y las partes interesadas pueden acceder tanto a la transmisión en vivo del webcast como a la repetición archivada de la charla informal a través de la sección de inversores en www.vorbio.com.
Vor Bio (Nasdaq: VOR)는 임상 단계의 세포 및 유전자 공학 회사로서 Oppenheimer의 제35회 연례 건강 및 생명 과학 컨퍼런스에 참석한다고 발표했습니다. 이 회사는 2월 12일 수요일 오후 12:00 ET에 예정된 화상 대화에 참여하고 투자자들과의 가상 1:1 미팅을 진행할 예정입니다.
이 행사는 가상으로 진행되며, 관심 있는 분들은 www.vorbio.com의 투자자 섹션을 통해 화상 대화의 생중계 및 아카이브 재방송에 접근할 수 있습니다.
Vor Bio (Nasdaq: VOR), une entreprise en phase clinique spécialisée dans l'ingénierie cellulaire et génique, a annoncé sa participation à la 35e Conférence Annuelle sur la Santé et les Sciences de la Vie d'Oppenheimer. L'entreprise participera à une discussion informelle prévue pour le mercredi 12 février à 12h00 ET et organisera des réunions virtuelles en tête-à-tête avec des investisseurs.
L'événement se déroulera virtuellement, et les parties intéressées peuvent accéder à la fois à la diffusion en direct ainsi qu'à la rediffusion archivée de la discussion informelle via la section investisseurs de www.vorbio.com.
Vor Bio (Nasdaq: VOR), ein Unternehmen in der klinischen Phase der Zell- und Genomtechnik, hat die Teilnahme an der 35. jährlichen Gesundheits- und Lebenswissenschaftskonferenz von Oppenheimer angekündigt. Das Unternehmen wird an einem Fireside-Chat teilnehmen, der für Mittwoch, den 12. Februar um 12:00 Uhr ET geplant ist, und virtuelle Einzelgespräche mit Investoren führen.
Die Veranstaltung findet virtuell statt, und interessierte Parteien können sowohl auf den Live-Webcast als auch auf die archivierte Wiederholung des Fireside-Chats über den Investorenbereich von www.vorbio.com zugreifen.
- None.
- None.
CAMBRIDGE, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and host virtual 1x1 investor meetings at the Oppenheimer’s 35th Annual Healthcare Life Sciences Conference.
Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
Fireside Chat: Wednesday, February 12th at 12:00pm ET
Location: Virtual
A live webcast and archived replay of the fireside chat will be available on the investors section of www.vorbio.com.
About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.
Contact:
Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com
FAQ
When is Vor Bio's fireside chat at Oppenheimer's Healthcare Conference?
How can investors access Vor Bio's presentation at the Oppenheimer Conference?
What type of meetings will VOR host at the Oppenheimer Healthcare Conference?
Is Vor Bio's participation in the Oppenheimer Conference virtual or in-person?
